Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Valeant Pharmaceuticals Intl Inc (VRX.TO)

Valeant Pharmaceuticals Intl Inc (VRX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,758,416
  • Shares Outstanding, K 349,299
  • Annual Sales, $ 8,724 M
  • Annual Income, $ 2,404 M
  • 60-Month Beta -1.49
  • Price/Sales 0.96
  • Price/Cash Flow N/A
  • Price/Book 1.85
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.64
  • Most Recent Earnings -7.68 on 03/31/18
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 1.000 on 11/10/10
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 1.04
  • Number of Estimates 6
  • High Estimate 1.19
  • Low Estimate 0.91
  • Prior Year 1.41
  • Growth Rate Est. (year over year) -26.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.80 +3.36%
on 07/06/18
35.73 -13.80%
on 06/15/18
-4.09 (-11.72%)
since 06/13/18
3-Month
21.10 +45.97%
on 04/16/18
36.02 -14.49%
on 06/13/18
+9.18 (+42.46%)
since 04/13/18
52-Week
14.01 +119.84%
on 11/02/17
36.02 -14.49%
on 06/13/18
+8.78 (+39.87%)
since 07/13/17

Most Recent Stories

More News
Valeant Pharmaceuticals International Inc. Securities Class Action

NOTICE OF AUTHORIZATION (CERTIFICATION) AND HEARING TO APPROVE PROPOSED SETTLEMENT WITH PRICEWATERHOUSECOOPERS LLP

VRX.TO : 30.80 (-3.33%)
Lannett Enters Into Distribution Agreement For Trientine Hydrochloride Capsules, Launch Imminent

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules, 250 mg,...

VRX.TO : 30.80 (-3.33%)
LCI : 8.98 (+2.51%)

Key Turning Points

2nd Resistance Point 32.69
1st Resistance Point 31.74
Last Price 30.80
1st Support Level 30.30
2nd Support Level 29.81

See More

52-Week High 36.02
Last Price 30.80
Fibonacci 61.8% 27.61
Fibonacci 50% 25.01
Fibonacci 38.2% 22.42
52-Week Low 14.01

See More

Business Summary

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar